Clinicopathologic study and Ki-67 proliferative marker evaluation in human osteosarcomas
Na minha lista:
| Autor principal: | |
|---|---|
| Data de Publicação: | 2005 |
| Outros Autores: | , , , , , |
| Formato: | Artigo |
| Idioma: | eng |
| Fonte: | Repositório Institucional da UnB |
| Texto Completo: | http://repositorio.unb.br/handle/10482/26549 https://dx.doi.org/10.1590/S1676-24442005000600008 |
Resumo: | BACKGROUND: Osteosarcoma is a relatively uncommon malignant neoplasm and little information has been reported on its cell proliferation using Ki-67. OBJECTIVES: Evaluate histological, clinical and immunohistochemical parameters using Ki-67 labeling index (LI), correlate one to another and with follow-up. MATERIAL AND METHOD: Fifty-seven patients with available clinicopathological data submitted to the study of cell proliferation as determined by Ki-67 expression measured by immunohistochemistry (IHC) staining using formalin-fixed paraffin embedded sections. In each sample, positive cells were quantified on at least a thousand nuclei and expressed as Ki-67 LI according to median value. RESULTS AND DISCUSSION: Non-significant correlations were observed in metastatic and non-metastatic cases when variables as surgery, tumor size, death and relapse were compared with Ki-67 LI values (cut-off of 45%). In the group of non-metastatic cases there was a direct correlation between higher values of Ki-67 index and better overall survival. Metastatic patients overall survival curve and LI high and low Ki-67 did not show significant differences. CONCLUSION: Based on our results the Ki-67 LI could be useful as a prognostic marker in patients without metastasis at diagnosis. |
Registros relacionados: Clinicopathologic study and Ki-67 proliferative marker evaluation in human osteosarcomas
- Expression of p53, Ki-67 and c-erb B2 in growth hormone-and/or prolactin-secreting pituitary adenomas
- Expressão da proteína Ki-67 e da glicoproteína MUC1 em carcinomas mucoepidermóide de glândulas salivares menores
- Isolation of osteosarcoma-associated human antibodies from a combinatorial fab phage display library
- Expressão de marcadores biológicos em câncer de mama antes e após a quimioterapia neoadjuvante. I- Correlações com desfechos clínicos e entre marcadores
- Câncer de boca : expressão imuno-histoquímica de c-erbB-2, Bcl-2 e EGFR : estudo comparativo com leucoplasia e hiperplasia inflamatória
- Expressão de proteínas de adesão (e-caderina e β - catenina) e proliferação celular (ki-67) no fronte de invasão tumoral de Carcinomas Espinocelular e Escamoso Basalóide